FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Anjali Advani

Research Profile

Disorders

Procedures

Concepts & Ideas

Phenomena

Recurrence

Chemicals & Drugs

Living Beings

Young Adult

Co-author Network

Publications

TOP 3
Valeria Visconte; Fabiola Traina; Anjali Advani; John Barnard; Manoj Bupathi; Edward Copelan; Kyoichi Isono; Anna Jankowska; Andres Jerez; Kazunori Koide; Haruhiko Koseki; Jaroslaw P Maciejewski; Hideki Makishima; James McMahon; Christine L O'Keefe; Sami Osman; Richard A Padgett; Heesun J Rogers; Yogen Saunthararajah; Mikkael A Sekeres; Jarnail Singh; Hadrian Szpurka; Ramon Tiu
SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes.
Nelli Bejanyan; Josephine Chan; Ania Jankowska; Matt Kalaycio; Jaroslaw P Maciejewski; Lindsey Mooney; Azra Raza; Yogen Saunthararajah; Anjali Advani; Ramon Tiu; Mikkael A Sekeres
A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF).
Yogen Saunthararajah; Mikkael Sekeres; Arun Singh; Ramon Tiu; Pierre Triozzi; Ed Copelan; Eric Hsi; Matt Kalaycio; Alan E Lichtin; Tomas Radivoyevitch; Frederic Reu; Brian Rini; Anjali Advani; Brian Bolwell
p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Anjali Advani (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Valeria Visconte; Fabiola Traina; Anjali Advani; John Barnard; Manoj Bupathi; Edward Copelan; Kyoichi Isono; Anna Jankowska; Andres Jerez; Kazunori Koide; Haruhiko Koseki; Jaroslaw P Maciejewski; Hideki Makishima; James McMahon; Christine L O'Keefe; Sami Osman; Richard A Padgett; Heesun J Rogers; Yogen Saunthararajah; Mikkael A Sekeres; Jarnail Singh; Hadrian Szpurka; Ramon Tiu
SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes.
Blood 2012;120(16):3173-86.
2012: Nelli Bejanyan; Josephine Chan; Ania Jankowska; Matt Kalaycio; Jaroslaw P Maciejewski; Lindsey Mooney; Azra Raza; Yogen Saunthararajah; Anjali Advani; Ramon Tiu; Mikkael A Sekeres
A phase 2 trial of combination therapy with thalidomide, arsenic trioxide, dexamethasone, and ascorbic acid (TADA) in patients with overlap myelodysplastic/myeloproliferative neoplasms (MDS/MPN) or primary myelofibrosis (PMF).
Cancer 2012;118(16):3968-76.
2012: Yogen Saunthararajah; Mikkael Sekeres; Arun Singh; Ramon Tiu; Pierre Triozzi; Ed Copelan; Eric Hsi; Matt Kalaycio; Alan E Lichtin; Tomas Radivoyevitch; Frederic Reu; Brian Rini; Anjali Advani; Brian Bolwell
p53-Independent, normal stem cell sparing epigenetic differentiation therapy for myeloid and other malignancies.
Seminars in oncology 2012;39(1):97-108.
2011: Manuel G Afable; Michael Clemente; Paul Elson; Matt Kalaycio; Alan E Lichtin; Hideki Makishima; Christine L O'Keefe; Mikkael A Sekeres; Mohammed Shaik; Yuka Sugimoto; Ramon Tiu; Anjali Advani; Jaroslaw P Maciejewski
Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia.
Haematologica 2011;96(9):1269-75.
2011: Mikkael A Sekeres; Cheryl L Willman; Deborah Mulford; Tom Norwood; Stephen H Petersdorf; Anjali Advani; Frederick R Appelbaum; Holly Gundacker; Jeffrey Lancet; Jane Liesveld; Alan F List
A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605.
Blood 2011;118(3):523-8.
2011: Hideki Makishima; Anna Jankowska; A MICHAEL MCDEVITT; Christine L O'Keefe; Simon Dujardin; Heather Cazzolli; Bartlomiej Przychodzen; Courtney Prince; John Nicoll; Harish Siddaiah; Mohammed Shaik; Hadrian Szpurka; Eric D Hsi; Anjali Advani; Ronald Paquette; Jaroslaw P Maciejewski
CBL, CBLB, TET2, ASXL1, and IDH1/2 mutations and additional chromosomal aberrations constitute molecular events in chronic myelogenous leukemia.
Blood 2011;117(21):e198-206.
2011: Anjali Advani; Sarah Gibson; Elizabeth Douglas; Julia Diacovo; Paul Elson; Matt Kalaycio; Edward A Copelan; Mikkael A Sekeres; Ronald Sobecks; Shawnda Sungren; Anand S Lagoo; David A Rizzieri; Eric D Hsi
Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL).
British journal of haematology 2011;153(4):504-7.
2011: Ramon Tiu; Lukasz Gondek; Christine L O'Keefe; Paul Elson; Jungwon Huh; Azim Mohamedali; Austin Kulasekararaj; Anjali Advani; Ronald Paquette; Alan F List; Mikkael A Sekeres; A MICHAEL MCDEVITT; Ghulam J Mufti; Jaroslaw P Maciejewski
Prognostic impact of SNP array karyotyping in myelodysplastic syndromes and related myeloid malignancies.
Blood 2011;117(17):4552-60.
2011: Mikkael A Sekeres; Jaroslaw P Maciejewski; Harry P Erba; Manuel Afable; Ricki Englehaupt; Ronald Sobecks; Anjali Advani; Sherry Seel; Josephine Chan; Matt E Kalaycio
A Phase 2 study of combination therapy with arsenic trioxide and gemtuzumab ozogamicin in patients with myelodysplastic syndromes or secondary acute myeloid leukemia.
Cancer 2011;117(6):1253-61.
2011: Anna K Brady; Alex Z Fu; Marc Earl; Matt Kalaycio; Anjali Advani; Yogen Saunthararajah; Ronald Sobecks; Edward A Copelan; Mikkael A Sekeres
Race and intensity of post-remission therapy in acute myeloid leukemia.
Leukemia research 2011;35(3):346-50.
2011: S D Smith; Brian J Bolwell; Lisa A Rybicki; T Kang; R Dean; Anjali Advani; Snehal G Thakkar; Ronald Sobecks; Matt Kalaycio; Brad Pohlman; John W Sweetenham
Comparison of outcomes after auto-SCT for patients with relapsed diffuse large B-cell lymphoma according to previous therapy with rituximab.
Bone marrow transplantation 2011;46(2):262-6.
2010: Anjali Advani; Mazyar Shadman; Francis Ali-Osman; Andrew Barker; Lisa Rybicki; Matt Kalaycio; Mikkael A Sekeres; Carlos M de Castro; Louis F Diehl; Joseph O Moore; Anne Beaven; Ed Copelan; Ronald Sobecks; Parisa Talea; David A Rizzieri
A Phase II trial of gemcitabine and mitoxantrone for patients with acute myeloid leukemia in first relapse.
Clinical lymphoma, myeloma & leukemia 2010;10(6):473-6.
2010: Anjali Advani; Holly Gundacker; Olga Sala-Torra; Jerald P Radich; Raymond Lai; Marilyn L Slovak; Jeffrey E Lancet; Steve E Coutre; Robert K Stuart; Martha P Mims; Patrick J Stiff; Frederick R Appelbaum
Southwest Oncology Group Study S0530: a phase 2 trial of clofarabine and cytarabine for relapsed or refractory acute lymphocytic leukaemia.
British journal of haematology 2010;151(5):430-4.
2010: Anjali Advani; Ramon Tiu; Yogen Saunthararajah; Jaroslaw Maciejewski; Edward A Copelan; Ronald Sobecks; Mikkael A Sekeres; Jennifer Bates; Mary Lynn Rush; Barbara Tripp; August Salvado; Elysa Noon; Matthew Howard; Tao Jin; Eric D Hsi; Merrill J Egorin; Kathleen Lim; Claudiu V Cotta; Courtney Price; Matt Kalaycio
A Phase 1 study of imatinib mesylate in combination with cytarabine and daunorubicin for c-kit positive relapsed acute myeloid leukemia.
Leukemia research 2010;34(12):1622-6.
2010: Nelli Bejanyan; Alex Z Fu; Aleksandr Lazaryan; Rao Fu; Matt Kalaycio; Anjali Advani; Ronald Sobecks; Edward Copelan; Jaroslaw P Maciejewski; Mikkael A Sekeres
Impact of weekend admissions on quality of care and outcomes in patients with acute myeloid leukemia.
Cancer 2010;116(15):3614-20.
2010: Anjali Advani; Bertrand Coiffier; Myron S Czuczman; Martin Dreyling; James Foran; Eva Gine; Christian Gisselbrecht; Nicolas Ketterer; Sunita Nasta; Ama Rohatiner; Ingo G H Schmidt-Wolf; Martin Schuler; Jorge Sierra; Mitchell R Smith; Gregor Verhoef; Jane N Winter; Joseph Boni; Erik Vandendries; Mark Shapiro; Luis Fayad
Safety, pharmacokinetics, and preliminary clinical activity of inotuzumab ozogamicin, a novel immunoconjugate for the treatment of B-cell non-Hodgkin's lymphoma: results of a phase I study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(12):2085-93.
2010: Anjali Advani; Kathleen Lim; Sarah Gibson; Mazyar Shadman; Tao Jin; Ed Copelan; Matt Kalaycio; Mikkael A Sekeres; Ronald Sobecks; Eric D Hsi
OCT-2 expression and OCT-2/BOB.1 co-expression predict prognosis in patients with newly diagnosed acute myeloid leukemia.
Leukemia & lymphoma 2010;51(4):606-12.
2010: Anjali Advani; Sarah E Gibson; Elizabeth Douglas; Tao Jin; Xiaoxian Zhao; Matt Kalaycio; Ed Copelan; Ronald Sobecks; Mikkael A Sekeres; Shawnda Sungren; Eric D Hsi
Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients.
BMC cancer 2010;10():387.
2009: Ramon Tiu; Lukasz Gondek; Christine L O'Keefe; Jungwon Huh; Mikkael A Sekeres; Paul Elson; A MICHAEL MCDEVITT; Xiao Fei Wang; Mark Levis; Judith E Karp; Anjali Advani; Jaroslaw P Maciejewski
New lesions detected by single nucleotide polymorphism array-based chromosomal analysis have important clinical impact in acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5219-26.
2009: Stephen D Smith; Brian J Bolwell; Anjali Advani; Steven Andresen; Josephine L Chan; Robert M Dean; Eric D Hsi; Matt Kalaycio; Brad Pohlman; Lisa A Rybicki; John W Sweetenham
High rate of survival in transformed lymphoma after autologous stem cell transplant: pathologic analysis and comparison with de novo diffuse large B-cell lymphoma.
Leukemia & lymphoma 2009;50(10):1625-31.
2009: Anjali Advani; Tao Jin; Brian J Bolwell; Edward Copelan; Mikkael A Sekeres; Ronald Sobecks; Shawnda Sungren; Melissa Yurch; Matt Kalaycio
A prognostic scoring system for adult patients less than 60 years of age with acute lymphoblastic leukemia in first relapse.
Leukemia & lymphoma 2009;50(7):1126-31.
2009: Anjali Advani; Mary J Laughlin
Umbilical cord blood transplantation for acute myeloid leukemia.
Current opinion in hematology 2009;16(2):124-8.
2008: Matt Kalaycio; Anjali Advani; Brad Pohlman; Mikkael A Sekeres; Barbara Tripp; Lisa Rybicki; Ronald Sobecks
Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemia.
American journal of hematology 2008;83(11):831-4.
2008: Anjali Advani; Cristina Rodriguez; Tao Jin; Rony Abou Jawde; Wael Saber; Rachid Baz; Matt Kalaycio; Ronald Sobecks; Mikkael A Sekeres; Barbara Tripp; Eric D Hsi
Increased C-kit intensity is a poor prognostic factor for progression-free and overall survival in patients with newly diagnosed AML.
Leukemia research 2008;32(6):913-8.
2008: Snehal G Thakkar; Alex Z Fu; John W Sweetenham; Zachariah A Mciver; Sanjay R Mohan; Giridharan Ramsingh; Anjali Advani; Ronald Sobecks; Lisa Rybicki; Matt Kalaycio; Mikkael A Sekeres
Survival and predictors of outcome in patients with acute leukemia admitted to the intensive care unit.
Cancer 2008;112(10):2233-40.
2008: Cristina P Rodriguez; Rachid Baz; Rony Abou Jawde; Lisa A Rybicki; Matt Kalaycio; Anjali Advani; Ronald Sobecks; Mikkael A Sekeres
Impact of socioeconomic status and distance from treatment center on survival in patients receiving remission induction therapy for newly diagnosed acute myeloid leukemia.
Leukemia research 2008;32(3):413-20.
2007: Tyler Y Kang; LA Rybicki; Brian J Bolwell; Snehal G Thakkar; S Brown; R Dean; Mikkael A Sekeres; Anjali Advani; Ronald Sobecks; Matt Kalaycio; Brad Pohlman; John Sweetenham
Effect of prior rituximab on high-dose therapy and autologous stem cell transplantation in follicular lymphoma.
Bone marrow transplantation 2007;40(10):973-8.
2007: Rachid Baz; Cristina Rodriguez; Alex Z Fu; Rony Abou Jawde; Matt Kalaycio; Anjali Advani; Ronald Sobecks; Mikkael A Sekeres
Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia.
Cancer 2007;110(8):1752-9.
2007: Matt Kalaycio; Lisa Rybicki; Brad Pohlman; R Dean; John Sweetenham; Steven Andresen; Ronald Sobecks; Mikkael A Sekeres; Anjali Advani; S Brown; Brian J Bolwell
Elevated lactate dehydrogenase is an adverse predictor of outcome in HLA-matched sibling bone marrow transplant for acute myelogenous leukemia.
Bone marrow transplantation 2007;40(8):753-8.
2007: Hyo Sook Han; Lisa A Rybicki; Karl Thiel; Matt Kalaycio; Ronald Sobecks; Anjali Advani; Stacey Brown; Mikkael A Sekeres
White blood cell count nadir following remission induction chemotherapy is predictive of outcome in older adults with acute myeloid leukemia.
Leukemia & lymphoma 2007;48(8):1561-8.
2006: Sarah E Gibson; Henry Y Dong; Anjali Advani; Eric D Hsi
Expression of the B cell-associated transcription factors PAX5, OCT-2, and BOB.1 in acute myeloid leukemia: associations with B-cell antigen expression and myelomonocytic maturation.
American journal of clinical pathology 2006;126(6):916-24.
2006: Rony M Abou-Jawde; Ronald Sobecks; Brad Pohlman; Lisa Rybicki; Anjali Advani; Mikkael A Sekeres; Matt Kalaycio
The role of post-remission chemotherapy for older patients with acute myelogenous leukemia.
Leukemia & lymphoma 2006;47(4):689-95.
2005: Anjali Advani
C-kit as a target in the treatment of acute myelogenous leukemia.
Current hematology reports 2005;4(1):51-8.